The agency announced Friday that it is keeping appointments in June for the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to meet to discuss emergency use authorization updates for vaccine makers Moderna and Pfizer/BioNTech that will include making younger ages eligible for the Covid-19 vaccination.
The dates for the provisional meeting of the VRBPAC are June 8, 21 and 22.
After the advisory committee’s deliberations, FDA officials could consider licensing vaccines for younger children — that decision also based on the agency’s reviews of vaccine data.
“We are providing a tentative timetable for discussing these requests, as these meetings will cover a number of topics of great interest to the general public,” Marks said. “The agency is committed to a comprehensive and transparent process that takes into account the input of our independent advisors and provides insight into our review of COVID-19 vaccines. We intend to move quickly with any appropriate clearances once our work is completed.”